Sentry Investment Management LLC cut its holdings in shares of CME Group Inc (NASDAQ:CME) by 8.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,067 shares of the financial services provider’s stock after selling 1,871 shares during the quarter. Sentry Investment Management LLC’s holdings in CME Group were worth $3,467,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Acadian Asset Management LLC boosted its holdings in CME Group by 591.0% during the fourth quarter. Acadian Asset Management LLC now owns 3,676 shares of the financial services provider’s stock worth $691,000 after buying an additional 3,144 shares during the last quarter. Norges Bank acquired a new position in shares of CME Group in the fourth quarter valued at $597,417,000. Thrivent Financial for Lutherans raised its stake in shares of CME Group by 8.2% in the fourth quarter. Thrivent Financial for Lutherans now owns 15,815 shares of the financial services provider’s stock valued at $2,975,000 after purchasing an additional 1,194 shares in the last quarter. First United Bank Trust raised its stake in shares of CME Group by 2.5% in the first quarter. First United Bank Trust now owns 7,725 shares of the financial services provider’s stock valued at $1,271,000 after purchasing an additional 185 shares in the last quarter. Finally, Public Employees Retirement System of Ohio raised its stake in shares of CME Group by 49.7% in the fourth quarter. Public Employees Retirement System of Ohio now owns 335,039 shares of the financial services provider’s stock valued at $63,028,000 after purchasing an additional 111,297 shares in the last quarter. Hedge funds and other institutional investors own 84.78% of the company’s stock.

Shares of NASDAQ:CME traded up $0.97 during trading on Tuesday, hitting $186.61. 431,310 shares of the company were exchanged, compared to its average volume of 1,785,468. The firm has a market capitalization of $66.28 billion, a price-to-earnings ratio of 27.36, a price-to-earnings-growth ratio of 4.21 and a beta of 0.32. CME Group Inc has a fifty-two week low of $157.21 and a fifty-two week high of $197.08. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.60 by $0.02. The firm had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.86 EPS. As a group, analysts anticipate that CME Group Inc will post 6.62 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.61%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio (DPR) is 43.99%.

In other news, Director Charles P. Carey sold 10,000 shares of CME Group stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $179.02, for a total transaction of $1,790,200.00. Following the completion of the transaction, the director now directly owns 37,799 shares in the company, valued at approximately $6,766,776.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $182.90, for a total value of $36,580.00. Following the transaction, the director now owns 3,600 shares of the company’s stock, valued at $658,440. The disclosure for this sale can be found here. Insiders have sold a total of 38,489 shares of company stock worth $6,739,196 in the last ninety days. Insiders own 1.20% of the company’s stock.

A number of research analysts recently commented on CME shares. JPMorgan Chase & Co. cut their target price on CME Group from $164.00 to $150.00 and set an “underweight” rating for the company in a research note on Friday, March 22nd. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, February 20th. Deutsche Bank lowered their target price on CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a research note on Friday, March 15th. Rosenblatt Securities cut CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Finally, ValuEngine cut CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 20th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $189.71.

WARNING: “Sentry Investment Management LLC Sells 1,871 Shares of CME Group Inc (CME)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.watchlistnews.com/sentry-investment-management-llc-sells-1871-shares-of-cme-group-inc-cme/3017874.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: What is diluted earnings per share (Diluted EPS)?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.